Welcome to our dedicated page for TRAVELERS COMPANIES SEC filings (Ticker: TRV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TRAVELERS COMPANIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TRAVELERS COMPANIES's regulatory disclosures and financial reporting.
The Travelers Companies, Inc. reported an insider equity award for executive Mojgan M. Lefebvre, EVP & Chief Tech & Ops Officer. The Form 4 shows a grant of 10,651 stock options (Right to Buy) on February 3, 2026.
These options allow the purchase of Travelers common stock at an exercise price of $288.23 per share. They become exercisable on February 3, 2029 and expire on February 3, 2036. Following this transaction, Lefebvre is reported as directly owning 10,651 derivative securities in the form of these options.
Travelers Companies executive Maria Olivo, EVP, ERM & Chief Risk Officer, received a grant of stock options on February 3, 2026. The award covers 10,773 stock options with a conversion or exercise price of $288.23 per share.
These options give the right to buy Travelers common stock and become exercisable on February 3, 2029, with an expiration date of February 3, 2036. Following this transaction, Olivo directly holds 10,773 derivative securities of this type.
The Travelers Companies, Inc. executive Jeffrey P. Klenk, EVP & President, Bond & Specialty Insurance, reported an award of stock options. On February 3, 2026, he acquired 12,854 stock options with a $288.23 exercise price, each for one share of common stock.
These options become exercisable on February 3, 2029 and expire on February 3, 2036. Following this grant, Klenk beneficially owns 12,854 derivative securities directly, as reflected in the filing.
The Travelers Companies, Inc. executive Rowland David Donnay, EVP & Co-Chief Investment Officer, reported a new stock option grant. On February 3, 2026, he was awarded 7,407 stock options with a conversion or exercise price of $288.23 per share.
These options relate to Travelers common stock, are held directly, and expire on February 3, 2036. Following this grant, Donnay beneficially owns 7,407 derivative securities in the form of these stock options.
The Travelers Companies, Inc. executive Michael Frederick Klein, EVP & President, Personal Insurance, reported acquiring stock options on the company’s common stock. On February 3, 2026, he acquired 16,649 stock options (right to buy) with a conversion or exercise price of $288.23 per share.
These options become exercisable on February 3, 2029 and expire on February 3, 2036. After this transaction, Klein beneficially owned 16,649 derivative securities, held directly in his name, with the derivative securities themselves reported at a price of $0.
The Travelers Companies, Inc. reported an insider equity award for its EVP & Chief Financial Officer, Daniel S. Frey. On February 3, 2026, he was granted stock options to buy 13,026 shares of Travelers common stock.
The options have an exercise price of $288.23 per share, become exercisable on February 3, 2029, and expire on February 3, 2036. Following this grant, Frey directly holds 13,026 stock options, with no indirect ownership reported in this filing.
The Travelers Companies, Inc. executive Yin Daniel Tei-Hwa, EVP & Co-Chief Investment Officer, reported a stock option award. On 02/03/2026, he received 7,407 stock options with an exercise price of $288.23 per share, expiring between 02/03/2029 and 02/03/2036.
Following this grant, he beneficially owns 7,407 derivative securities directly.
Travelers Companies executive Gregory C. Toczydlowski received a new stock option grant. On February 3, 2026, he was awarded 17,629 stock options to buy Travelers common stock at an exercise price of $288.23 per share. These options become exercisable on February 3, 2029 and expire on February 3, 2036. Following this award, he beneficially owns 17,629 derivative securities directly.
Travelers Companies’ Chairman and CEO Alan D. Schnitzer reported multiple equity transactions in early February 2026. On February 4, 2026, he exercised 216,246 stock options at $126.18 per share, receiving the same number of common shares.
That day, Schnitzer had 160,513 shares withheld to cover obligations at $294.36 per share and sold additional common stock in three blocks: 26,509 shares at $294.1802, 23,078 shares at $295.0001, and 6,146 shares at $295.8154, based on weighted-average pricing ranges. After these trades, he directly owned 260,329.401 shares of Travelers common stock.
Separately, on February 3, 2026, Schnitzer was granted 88,389 stock options with an exercise price of $288.23, exercisable beginning February 3, 2029 and expiring February 3, 2036. The filing also notes 11,091 shares held indirectly by his spouse, for which he disclaims beneficial ownership.
The Travelers Companies, Inc. reported that EVP and Chief Admin Officer Andy F. Bessette received a grant of stock options. On February 3, 2026, he was awarded options to buy 6,427 shares of Travelers common stock at an exercise price of $288.23 per share.
These options relate to 6,427 underlying common shares, become exercisable on February 3, 2029, and expire on February 3, 2036. Following this grant, Bessette directly beneficially owns 6,427 derivative securities in the form of these stock options.